Insigneo Advisory Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.12M Buy
16,641
+10,887
+189% +$2.05M 0.12% 124
2026
Q1
$1.12M Buy
5,754
+1,193
+26% +$230K 0.08% 200
2025
Q4
$838K Sell
4,561
-151
-3% -$26.5K 0.06% 246
2025
Q3
$723K Buy
4,712
+646
+16% +$97.8K 0.05% 267
2025
Q2
$568K Buy
4,066
+25
+0.6% +$3.5K 0.05% 307
2025
Q1
$594K Sell
4,041
-20
-0.5% -$2.89K 0.06% 255
2024
Q4
$532K Sell
4,061
-840
-17% -$118K 0.06% 280
2024
Q3
$764K Buy
4,901
+789
+19% +$127K 0.08% 216
2024
Q2
$652K Sell
4,112
-699
-15% -$105K 0.07% 233
2024
Q1
$652K Buy
+4,811
New +$637K 0.08% 212
2023
Q4
Sell
-3,581
Closed -$485K 437
2023
Q3
$485K Buy
3,581
+511
+17% +$69.8K 0.1% 193
2023
Q2
$439K Buy
3,070
+69
+2% +$10.2K 0.08% 220
2023
Q1
$417K Buy
3,001
+62
+2% +$8.34K 0.13% 163
2022
Q4
$398K Buy
+2,939
New +$369K 0.15% 150

Other funds holding AZN

Insigneo Advisory Services's AZN Position: Q2 2026 in Review

Insigneo Advisory Services increased its AstraZeneca (AZN) stake by 189% in Q2 2026, buying an estimated $2.05M and bringing the position to 16,641 shares worth $3.12M. The position accounts for 0.12% of the portfolio, ranked #124.

Insigneo Advisory Services first reported a position in AZN in Q4 2022 and has held it in 14 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Insigneo Advisory Services held 16,641 shares of AstraZeneca worth $3.12M as of Q2 2026.
  • Insigneo Advisory Services bought 10,887 AstraZeneca shares in Q2 2026, an estimated $2.05M.
  • AstraZeneca made up 0.12% of Insigneo Advisory Services's portfolio in Q2 2026, its #124 holding.
  • Insigneo Advisory Services first reported a position in AstraZeneca in Q4 2022 and has held it in 14 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Insigneo Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.